QIDP Roundup: Familiar Names Dominate 2019 Designations

 
• By Bridget Silverman

US FDA's Qualified Infectious Disease Product program is growing slowly, but still growing.

Antibiotic-resistant-bacteria

More from Review Pathways

More from Pathways & Standards